NMDA receptor antagonists inhibit opiate antinociceptive tolerance and locomotor sensitization in rats

Psychopharmacology

Volumn 196, Issue 3, 2008, Pages 497-509

  Mendez, Ian A ^a,b   Trujillo, Keith A ^b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

Analgesia; Locomotion; NMDA receptor; Opiate; Sensitization; Tolerance

Indexed keywords

BUPRENORPHINE; DECAHYDRO 6 PHOSPHONOMETHYL 3 ISOQUINOLINECARBOXYLIC ACID; DIZOCILPINE; MEMANTINE; METHADONE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OPIATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG SENSITIZATION; DRUG TOLERANCE; LOCOMOTION; MALE; NERVE CELL PLASTICITY; NOCICEPTION; NONHUMAN; OPIATE ADDICTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANIMALS; BEHAVIOR, ANIMAL; BUPRENORPHINE; DIZOCILPINE MALEATE; DRUG TOLERANCE; EXCITATORY AMINO ACID ANTAGONISTS; ISOQUINOLINES; MALE; MEMANTINE; METHADONE; MORPHINE; MOTOR ACTIVITY; NARCOTICS; OPIOID-RELATED DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 38949123202     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-007-0984-8     Document Type: Article

References (58)

1. Allen RM, Dykstra LA (1999) The competitive NMDA receptor antagonist LY235959 modulates the progression of morphine tolerance in rats. Psychopharmacology 142:209-214
2. Allen RM, Dykstra LA (2000a) Attenuation of mu-opioid tolerance and cross-tolerance by the competitive N-methyl-d-aspartate receptor antagonist LY235959 is related to tolerance and cross-tolerance magnitude. J Pharmacol Exp Ther 295:1012-1021
3. Allen RM, Dykstra LA (2000b) Role of morphine maintenance dose in the development of tolerance and its attenuation by an NMDA receptor antagonist. Psychopharmacology 148:59-65
4. Atalla A, Kuschinsky K (2006) Effects of blockade of glutamate NMDA receptors or of NO synthase on the development or the expression of associative or non-associative sensitization to locomotor activation by morphine. J Neural Transm V113:1-10
5. Bell RF, Dahl JB, Moore RA, Kalso E (2005) Peri-operative ketamine for acute post-operative pain: a quantitative and qualitative systematic review (Cochrane review). Acta Anaesthesiol Scand 49:1405-1428
6. Belozertseva IV, Bespalov A (1998) Effects of NMDA receptor channel blockers, dizocilpine and memantine, on the development of opiate analgesic tolerance induced by repeated morphine exposures or social defeats in mice. Naunyn-Schmiedebergs Arch Pharmacol 358:270-274
7. Ben-Eliyahu S, Marek P, Vaccarino AL, Mogil JS, Sternberg WF, Liebeskind JC (1992) The NMDA receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the rat. Brain Res 575:304-308
8. Bilsky EJ, Inturrisi CE, Sadee W, Hruby VJ, Porreca F (1996) Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective μ or ∂ opioid agonists in mice. Pain 68:229-237
9. Bisaga A, Popik P (2000) In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-d-aspartate (NMDA) antagonists. Drug Alcohol Depend 59:1-15
10. Bubser M, Keseberg U, Notz PK, Schmidt WJ (1992) Differential behavioral and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats. Eur J Pharmacol 229:75-82
11. Carlezon WA Jr, Mendrek A, Wise RA (1995) MK-801 disrupts the expression but not the development of bromocriptine sensitization: a state-dependency interpretation. Synapse 20:1-9
12. Carlezon WA Jr, Kosten TA, Nestler EJ (2000) Behavioral interactions caused by combined administration of morphine and MK-801 in rats. Psychopharmacology 151:261-272
13. Carter AJ (1994) Many agents that antagonize the NMDA receptor-channel complex in vivo also cause disturbances of motor coordination. J Pharmacol Exp Ther 269:573-580
14. Danysz W, Parsons CG (1998) Glycine and N-methyl-d-aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol Rev 50:597-664
15. Danysz W, Essman U, Bresink I, Wilke R (1994) Glutamate antagonists have different effects on spontaneous locomotor activity in rats. Pharmacol Biochem Behav 48:111-118
16. Geter-Douglass B, Witkin JM (1997) Dizocilpine-like discriminative stimulus effects of competitive NMDA receptor antagonists in mice. Psychopharmacology (Berl) 133:43-50
17. Geter-Douglass B, Witkin JM (1999) Behavioral effects and anticonvulsant efficacies of low-affinity, uncompetitive NMDA antagonists in mice. Psychopharmacology (Berl) 146:280-289
18. Gutstein HB, Trujillo KA (1993) MK-801 inhibits the development of morphine tolerance at spinal sites. Brain Res 626:332-334
19. Herman BH, Vocci F, Bridge P (1995) The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal. Medication development issues for opiate addiction. Neuropsychopharmacology 13:269-293
20. Iijima Y, Asami T, Kuribara H (1996) Modification by MK-801(dizocilpine), a noncompetitive NMDA receptor antagonist, of morphine sensitization: evaluation by ambulation in mice. Japanese Journal of Psychopharmacology 16:11-18
21. Inturrisi CE (1997) Preclinical evidence for a role of glutamatergic systems in opioid tolerance and dependence. Semin Neurosci 9:110-119
22. Jeziorski M, White FJ, Wolf ME (1994) MK-801 prevents the development of behavioral sensitization during repeated morphine administration. Synapse 16:137-147
23. Kosten TA, Bombace JC (2000) Prior and delayed applications of dizocilpine or ethanol alter locomotor sensitization to morphine. Brain Res 878:20-31
24. Li Y, Wolf ME (1999) Can the " state-dependency" hypothesis explain prevention of amphetamine sensitization in rats by NMDA receptor antagonists? Psychopharmacology (Berl) 141:351-61
25. Lodge D, Danysz W, Parsons CG (2002) Ionotropic glutamate receptors as therapeutic targets. F.P. Graham, Johnson City, TN
26. Mao J (1999) NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticity. Brain Res Rev 30:289-304
27. Mao J, Price DD, Lu J, Mayer DJ (1998) Antinociceptive tolerance to the mu-opioid agonist DAMGO is dose-dependently reduced by MK-801 in rats. Neurosci Lett 250:193-196
28. Marek P, Ben-Eliyahu S, Vaccarino AL, Liebeskind JC (1991) Delayed application of MK-801 attenuates development of morphine tolerance in rats. Brain Res 558:163-165
29. Mayer DJ, Mao J (1999) Mechanisms of opioid tolerance: a current view of cellular mechanisms. Pain Forum 8:14-18
30. Mayer DJ, Mao J, Holt J, Price DD (1999) Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. Proc Natl Acad Sci U S A 96:7731-7736
31. Miyamoto Y, Yamada K, Nagai T, Mori H, Mishina M, Furukawa H, Noda Y, Nabeshima T (2004) Behavioural adaptations to addictive drugs in mice lacking the NMDA receptor epsilon1 subunit. Eur J Neurosci 19:151-158
32. Parsons CG, Danysz W, Quack G (1999) Memantine is a clinically well-tolerated N-methyl-d-aspartate (NMDA) receptor antagonists-a review of preclinical data. Neuropharmacology 38:735-767
33. Peterson DJ (2003) The effects of memantine on opiate tolerance, sensitization and physical dependence department of psychology. California State University, San Marcos
34. Peterson DJ, Mendez IA, Lewellen RM, Trujillo KA (2002) NMDA receptor antagonists prevent and slowly reverse opiate-induced behavioral and neural plasticity. In International Narcotics Research Conference, Asilomar, CA
35. Popik P, Kozela E (1999) Clinically available NMDA antagonist, memantine, attenuates tolerance to analgesic effects of morphine in a mouse tail flick test. Pol J Pharmacol 51:223-231
36. Popik P, Kozela E, Danysz W (2000) Clinically available NMDA receptor antagonists memantine and dextromethorphan reverse existing tolerance to the antinociceptive effects of morphine in mice. Naunyn-Schmiedebergs Arch Pharmacol 361:425-432
37. Ranaldi R, Munn E, Neklesa T, Wise RA (2000) Morphine and amphetamine sensitization in rats demonstrated under moderate- and high-dose NMDA receptor blockade with MK-801 (dizocilpine). Psychopharmacology 151:192-201
38. Redwine KE, Trujillo KA (2003) Effects of NMDA receptor antagonists on acute mu opioid analgesia in the rat. Pharmacol Biochem Behav 76:361-372
39. Shimoyama N, Shimoyama M, Davis AM, Monaghan DT, Inturrisi CE (2005) An antisense oligonucleotide to the N-methyl-d-aspartate (NMDA) Subunit NMDAR1 Attenuates NMDA-induced nociception, hyperalgesia, and morphine tolerance. J Pharmacol Exp Ther 312:834-840
40. Subramaniam K, Subramaniam B, Steinbrook RA (2004) Ketamine as adjuvant analgesic to opioids: a quantitative and qualitative systematic review. Anesth Analg 99:482-495
41. Swadley-Lewellen RM, Trujillo KA (1998) Are NMDA receptors involved in tolerance and sensitization to the locomotor effects of morphine? Society for Neuroscience Abstracts 24:1968
42. Tiseo PJ, Inturrisi CE (1993) Attenuation and reversal of morphine tolerance by the competitive N-methyl-d-aspartate receptor antagonist LY274614. J Pharmacol Exp Ther 264:1090-1096
43. Trujillo KA (1995) Effects of non-competitive N-methyl-d-aspartate receptor antagonists on opiate tolerance and physical dependence. Neuropsychopharmacology 13:301-307
44. Trujillo KA (2000) Are NMDA receptors involved in opiate-induced neural and behavioral plasticity? A review of preclinical findings. Psychopharmacology 151:121-141
45. Trujillo KA (2002) The neurobiology of opiate tolerance, dependence and sensitization: Mechanisms of NMDA receptor-dependent synaptic plasticity. Neurotox Res 4:373-391
46. Trujillo KA, Akil H (1991) Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251:85-87
47. Trujillo KA, Akil H (1994) Inhibition of opiate tolerance by non-competitive N-methyl-d-aspartate receptor antagonists. Brain Res 633:178-188
48. Trujillo KA, Akil H (1995) Excitatory amino acids and drugs of abuse: a role for N-methyl-d-aspartate receptors in drug tolerance, sensitization and physical dependence. Drug Alcohol Depend 38:139-154
49. Trujillo KA, Warmoth KP, Peterson DJ, Albertson DN, Swadley-Lewellen RM (2000) Potential role for NMDA receptors in acute locomotor effects of opiates. Society for Neuroscience Abstracts 26:272
50. Trujillo KA, Warmoth KP, Mendez IA, Watorski K, Peterson DJ, Albertson DN, Swadley-Lewellen RM (2001a) Contrasting effects of NMDA receptor antagonists on opiate analgesia and locomotion. Drug Alcohol Depend 63(Suppl 1):S159-S160
51. Trujillo KA, Warmoth KP, Peterson DJ, Albertson DN, Watorski K, Swadley-Lewellen RM (2001b) NMDA receptor antagonists inhibit the development of tolerance and sensitization to the locomotor effects of opiates. Society for Neuroscience Abstracts 27, Abstract #224.11
52. Tzschentke TM, Schmidt WJ (1996) Procedural examination of behavioral sensitisation to morphine: lack of blockade by MK-801, occurrence of sensitised sniffing, and evidence for cross-sensitisation between morphine and MK-801. Behav Pharmacol 7:169-184
53. Tzschentke TM, Schmidt WJ (1998) Does the non-competitive NMDA receptor antagonist dizocilpine (MK-801) really block behavioral sensitization associated with repeated drug administration? Trends Pharmacol Sci 19:447-451
54. Tzschentke TM, Schmidt WJ (2000) Effects of the non-competitive NMDA-receptor antagonist memantine on morphine- and cocaine-induced potentiation of lateral hypothalamic brain stimulation reward. Psychopharmacology 149:225-234
55. Vanderschuren LJ, Kalivas PW (2000) Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology 151:99-120
56. Vanderschuren LJ, Schoffelmeer AN, De Vries TJ (1997) Does dizocilpine (MK-801) inhibit the development of morphine-induced behavioral sensitization in rats? Life Sci 61:427-433
57. Wolf ME (1998) The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog Neurobiol 54:679-720
58. Wolf ME, Jeziorski M (1993) Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization. Brain Res 613:291-294